Division of DNA Repair and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Nucleic Acids Res. 2013 Feb 1;41(3):e50. doi: 10.1093/nar/gks1250. Epub 2012 Dec 20.
Detection of low-level DNA variations in the presence of wild-type DNA is important in several fields of medicine, including cancer, prenatal diagnosis and infectious diseases. PCR-based methods to enrich mutations during amplification have limited multiplexing capability, are mostly restricted to known mutations and are prone to polymerase or mis-priming errors. Here, we present Differential Strand Separation at Critical Temperature (DISSECT), a method that enriches unknown mutations of targeted DNA sequences purely based on thermal denaturation of DNA heteroduplexes without the need for enzymatic reactions. Target DNA is pre-amplified in a multiplex reaction and hybridized onto complementary probes immobilized on magnetic beads that correspond to wild-type DNA sequences. Presence of any mutation on the target DNA forms heteroduplexes that are subsequently denatured from the beads at a critical temperature and selectively separated from wild-type DNA. We demonstrate multiplexed enrichment by 100- to 400-fold for KRAS and TP53 mutations at multiple positions of the targeted sequence using two to four successive cycles of DISSECT. Cancer and plasma-circulating DNA samples containing traces of mutations undergo mutation enrichment allowing detection via Sanger sequencing or high-resolution melting. The simplicity, scalability and reliability of DISSECT make it a powerful method for mutation enrichment that integrates well with existing downstream detection methods.
在存在野生型 DNA 的情况下检测低水平 DNA 变异在多个医学领域都很重要,包括癌症、产前诊断和传染病。基于 PCR 的方法在扩增过程中富集突变的能力有限,大多局限于已知的突变,并且容易出现聚合酶或错误引物的错误。在这里,我们提出了差异化链在临界温度下分离(Differential Strand Separation at Critical Temperature,DISSECT),这是一种仅基于 DNA 异源双链体的热变性而无需酶反应即可富集靶向 DNA 序列中未知突变的方法。目标 DNA 在多重反应中进行预扩增,并杂交到与野生型 DNA 序列相对应的固定在磁性珠上的互补探针上。目标 DNA 上的任何突变都会形成异源双链体,随后在临界温度下从珠上变性,并与野生型 DNA 选择性分离。我们证明了通过 DISSECT 在靶向序列的多个位置进行 KRAS 和 TP53 突变的多重富集,使用两到四个连续的 DISSECT 循环可实现 100 至 400 倍的富集。含有突变痕迹的癌症和血浆循环 DNA 样本可进行突变富集,允许通过 Sanger 测序或高分辨率熔解进行检测。DISSECT 的简单性、可扩展性和可靠性使其成为一种强大的突变富集方法,与现有的下游检测方法很好地集成。